Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy
PLOS One · 14.05.2025 · 20 (5) · e0312208
DOI: 10.1371/journal.pone.0312208 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 14.05.2025. Verfasst von Andres Portocarrero-Bonifaz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky, United States of America. Hauptthemen laut MEDLINE: Machine Learning, Brachytherapy, Genital Neoplasms, Female. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Künstliche Intelligenz in der Pflege, Onkologische Pflege
Abstract (Originalsprache)
Background
Gynecological cancers are among the most prevalent cancers in women worldwide. Brachytherapy, often used as a boost to external beam radiotherapy, is integral to treatment. Advances in computation, algorithms, and data availability have popularized the use of machine learning to predict patient outcomes. Recent studies have applied models such as logistic regression, support vector machines, and deep learning networks to predict specific toxicities in patients who have undergone brachytherapy.
Objective
To develop and compare machine learning models for predicting grade 3 or higher toxicities in gynecological cancer patients treated with high dose rate (HDR) brachytherapy, aiming to contribute to personalized radiation treatments.
Methods
A retrospective analysis was performed on gynecological cancer patients who underwent HDR brachytherapy with Syed-Neblett or Tandem and Ovoid applicators from 2009 to 2023. After applying exclusion criteria, 233 patients were included in the analysis. Dosimetric variables for the high-risk clinical target volume (HR-CTV) and organs at risk, along with tumor, patient, and toxicity data, were collected and compared between groups with and without grade 3 or higher toxicities using statistical tests. Seven supervised classification machine learning models (Logistic Regression, Random Forest, K-Nearest Neighbors, Support Vector Machines, Gaussian Naive Bayes, Multi-Layer Perceptron Neural Networks, and XGBoost) were constructed and evaluated. The training process involved sequential feature selection (SFS) when appropriate, followed by hyperparameter tuning. Final model performance was characterized using a 25% withheld test dataset.
Results
The top three ranking models were Support Vector Machines, Random Forest, and Logistic Regression, with F1 testing scores of 0.63, 0.57, and 0.52; normMCC testing scores of 0.75, 0.77, and 0.71; and accuracy testing scores of 0.80, 0.85, and 0.81, respectively. The SFS algorithm selected 10 features for the highest-ranking model. In traditional statistical analysis, HR-CTV volume, Charlson Comorbidity Index, Length of Follow-Up, and D2cc - Rectum differed significantly between groups with and without grade 3 or higher toxicities.
Conclusions
Machine learning models were developed to predict grade 3 or higher toxicities, achieving satisfactory performance. Machine learning presents a novel solution to creating multivariable models for personalized radiation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
- Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, United States of America.
- Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Loma Linda University Medical Center, Loma Linda, California, United States of America.
- Department of Bioinformatics and Biostatistics, University of Louisville School of Public Health and Information Sciences, Louisville, Kentucky, United States of America.
- Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
ORCID-Profile: Andres Portocarrero-Bonifaz, Jeremy T Gaskins, Keith T Sowards, Scott R Silva
Zitieren
APA
Portocarrero-Bonifaz, A., Syed, S., Kassel, M., McKenzie, G. W., Shah, V. M., Forry, B. M., Gaskins, J. T., Sowards, K. T., Avula, T. B., Masters, A., Schneider, J. G., & Silva, S. R. (2025). Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy. PLOS One, 20(5), e0312208. https://doi.org/10.1371/journal.pone.0312208
Vancouver
Portocarrero-Bonifaz A, Syed S, Kassel M, McKenzie GW, Shah VM, Forry BM, et al. Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy. PLOS One. 2025;20(5):e0312208. doi:10.1371/journal.pone.0312208
BibTeX
@article{PortocarreroBonifaz2025,
author = {Portocarrero-Bonifaz, Andres and Syed, Salman and Kassel, Maxwell and McKenzie, Grant W and Shah, Vishwa M and Forry, Bryce M and Gaskins, Jeremy T and Sowards, Keith T and Avula, Thulasi Babitha and Masters, Adrianna and Schneider, Jose G and Silva, Scott R},
title = {Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {5},
pages = {e0312208},
doi = {10.1371/journal.pone.0312208}
}
EUVIMED